Market Closed -
London S.E.
11:35:05 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1,408
GBX
|
+0.57%
|
|
-7.00%
|
+18.82%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
377.9
|
1,091
|
2,441
|
3,057
|
2,060
|
2,375
|
-
|
-
|
Enterprise Value (EV)
1 |
-443.1
|
518.3
|
1,581
|
2,523
|
1,983
|
2,031
|
1,876
|
1,539
|
P/E ratio
|
2.87
x
|
-7.44
x
|
12.9
x
|
-58.9
x
|
1,508
x
|
9.43
x
|
7.24
x
|
5.55
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.48
x
|
1.69
x
|
3.09
x
|
3.39
x
|
1.88
x
|
1.87
x
|
1.67
x
|
1.51
x
|
EV / Revenue
|
-0.56
x
|
0.8
x
|
2
x
|
2.8
x
|
1.81
x
|
1.6
x
|
1.32
x
|
0.98
x
|
EV / EBITDA
|
-2
x
|
4.89
x
|
7.83
x
|
11.2
x
|
6.88
x
|
5.35
x
|
4.12
x
|
2.79
x
|
EV / FCF
|
-2.97
x
|
-2.63
x
|
4.67
x
|
-11.1
x
|
-4.8
x
|
5.37
x
|
6.61
x
|
3.25
x
|
FCF Yield
|
-33.6%
|
-38%
|
21.4%
|
-9%
|
-20.8%
|
18.6%
|
15.1%
|
30.8%
|
Price to Book
|
-
|
-
|
-
|
61.1
x
|
-
|
10.5
x
|
3.92
x
|
2.23
x
|
Nbr of stocks (in thousands)
|
146,153
|
146,701
|
140,437
|
136,489
|
136,551
|
135,438
|
-
|
-
|
Reference price
2 |
2.586
|
7.439
|
17.38
|
22.40
|
15.08
|
17.54
|
17.54
|
17.54
|
Announcement Date
|
2/13/20
|
2/18/21
|
2/16/22
|
2/16/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
785
|
647
|
791
|
901
|
1,093
|
1,273
|
1,419
|
1,573
|
EBITDA
1 |
222
|
106
|
202
|
225
|
288
|
379.5
|
455.4
|
552
|
EBIT
1 |
202
|
88
|
187
|
212
|
269
|
355.9
|
430
|
522.8
|
Operating Margin
|
25.73%
|
13.6%
|
23.64%
|
23.53%
|
24.61%
|
27.96%
|
30.31%
|
33.23%
|
Earnings before Tax (EBT)
1 |
180
|
-173
|
190
|
-95
|
1
|
326
|
409.8
|
543
|
Net income
1 |
134
|
-148
|
205
|
-53
|
2
|
267.8
|
341.2
|
439.8
|
Net margin
|
17.07%
|
-22.87%
|
25.92%
|
-5.88%
|
0.18%
|
21.04%
|
24.04%
|
27.96%
|
EPS
2 |
0.9000
|
-1.000
|
1.350
|
-0.3800
|
0.0100
|
1.860
|
2.423
|
3.160
|
Free Cash Flow
1 |
149
|
-197
|
339
|
-227
|
-413
|
378.4
|
284
|
473.8
|
FCF margin
|
18.98%
|
-30.45%
|
42.86%
|
-25.19%
|
-37.79%
|
29.74%
|
20.02%
|
30.12%
|
FCF Conversion (EBITDA)
|
67.12%
|
-
|
167.82%
|
-
|
-
|
99.71%
|
62.37%
|
85.84%
|
FCF Conversion (Net income)
|
111.19%
|
-
|
165.37%
|
-
|
-
|
141.31%
|
83.25%
|
107.73%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/13/20
|
2/18/21
|
2/16/22
|
2/16/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
222
|
-
|
221
|
253
|
276
|
271
|
293
|
284
|
305.6
|
328.2
|
344.4
|
358.8
|
362.5
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
77
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
32
|
-
|
-
|
71
|
71
|
60
|
66
|
70
|
76
|
96.5
|
110.9
|
107.5
|
107
|
Operating Margin
|
14.41%
|
-
|
-
|
28.06%
|
25.72%
|
22.14%
|
22.53%
|
24.65%
|
24.87%
|
29.41%
|
32.2%
|
29.96%
|
29.52%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
62
|
-181
|
61
|
63
|
69.2
|
89.7
|
104.1
|
101.9
|
101.4
|
Net income
1 |
-
|
41
|
-
|
44
|
39
|
-135
|
54
|
47
|
58.65
|
70.55
|
79.6
|
78.4
|
78.1
|
Net margin
|
-
|
-
|
-
|
17.39%
|
14.13%
|
-49.82%
|
18.43%
|
16.55%
|
19.19%
|
21.5%
|
23.11%
|
21.85%
|
21.54%
|
EPS
2 |
-
|
0.3000
|
-
|
0.3100
|
-
|
-0.9800
|
0.3800
|
0.3400
|
0.4250
|
0.5200
|
0.5850
|
0.5800
|
0.5800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/16/22
|
4/28/22
|
7/28/22
|
4/27/23
|
7/27/23
|
11/9/23
|
2/22/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
821
|
573
|
860
|
534
|
77
|
344
|
499
|
836
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
149
|
-197
|
339
|
-227
|
-413
|
378
|
284
|
474
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
133%
|
875%
|
274%
|
91.4%
|
55.3%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
0.3700
|
-
|
1.670
|
4.470
|
7.880
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
7
|
4
|
14
|
5
|
8
|
31
|
36
|
9.6
|
Capex / Sales
|
0.89%
|
0.62%
|
1.77%
|
0.55%
|
0.73%
|
2.44%
|
2.54%
|
0.61%
|
Announcement Date
|
2/13/20
|
2/18/21
|
2/16/22
|
2/16/23
|
2/22/24
|
-
|
-
|
-
|
Last Close Price
17.54
USD Average target price
31.03
USD Spread / Average Target +76.93% Consensus |
1st Jan change
|
Capi.
|
---|
| +18.82% | 2.38B | | +5.31% | 70.44B | | +10.97% | 8.94B | | -16.83% | 4.75B | | +43.48% | 4.5B | | +3.20% | 3.85B | | -21.36% | 2.34B | | -29.67% | 2.2B | | +8.38% | 1.96B | | -0.50% | 1.64B |
Specialty & Advanced Pharmaceuticals
|